This page is part of the US Drug Formulary (v1.1.0: STU 1) based on FHIR R4. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions
{
"resourceType" : "MedicationKnowledge",
"id" : "cmsip9",
"meta" : {
"profile" : [
"http://hl7.org/fhir/us/davinci-drug-formulary/StructureDefinition/usdf-FormularyDrug"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>Drug Tier ID</b>: <span title=\"Codes: {http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS generic}\">Generic</span></p><p><b>Prior Authorization</b>: false</p><p><b>Step Therapy Limit</b>: true</p><p><b>Quantity Limit</b>: true</p><p><b>Plan ID</b>: 40308VA0240008</p><p><b>code</b>: <span title=\"Codes: {http://www.nlm.nih.gov/research/umls/rxnorm 1000091}\">doxepin hydrochloride 50 MG/ML Topical Cream</span></p></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/us/davinci-drug-formulary/StructureDefinition/usdf-DrugTierID-extension",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS",
"code" : "generic",
"display" : "Generic"
}
]
}
},
{
"url" : "http://hl7.org/fhir/us/davinci-drug-formulary/StructureDefinition/usdf-PriorAuthorization-extension",
"valueBoolean" : false
},
{
"url" : "http://hl7.org/fhir/us/davinci-drug-formulary/StructureDefinition/usdf-StepTherapyLimit-extension",
"valueBoolean" : true
},
{
"url" : "http://hl7.org/fhir/us/davinci-drug-formulary/StructureDefinition/usdf-QuantityLimit-extension",
"valueBoolean" : true
},
{
"url" : "http://hl7.org/fhir/us/davinci-drug-formulary/StructureDefinition/usdf-PlanID-extension",
"valueString" : "40308VA0240008"
}
],
"code" : {
"coding" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1000091",
"display" : "doxepin hydrochloride 50 MG/ML Topical Cream"
}
]
}
}